Insider Buying: Axcella Health Inc (NASDAQ:AXLA) Director Buys 4,556 Shares of Stock

Axcella Health Inc (NASDAQ:AXLA) Director David R. Epstein purchased 4,556 shares of the company’s stock in a transaction dated Wednesday, July 3rd. The stock was purchased at an average cost of $8.76 per share, for a total transaction of $39,910.56. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Shares of NASDAQ:AXLA traded up $0.60 on Friday, hitting $8.08. The stock had a trading volume of 6,900 shares, compared to its average volume of 36,709. Axcella Health Inc has a twelve month low of $6.83 and a twelve month high of $15.99. The company has a 50 day moving average of $9.62.

Axcella Health (NASDAQ:AXLA) last issued its earnings results on Thursday, June 20th. The company reported ($2.43) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.39) by ($2.04). On average, equities research analysts predict that Axcella Health Inc will post -3.05 earnings per share for the current fiscal year.

AXLA has been the topic of a number of research reports. Goldman Sachs Group assumed coverage on shares of Axcella Health in a research report on Sunday, June 2nd. They set a “buy” rating and a $25.00 target price on the stock. Svb Leerink assumed coverage on shares of Trevi Therapeutics in a research note on Monday, June 3rd. They set an “outperform” rating and a $14.00 price target on the stock. Leerink Swann began coverage on shares of Trevi Therapeutics in a research note on Monday, June 3rd. They set an “outperform” rating on the stock. Finally, JPMorgan Chase & Co. upgraded shares of ROYAL MAIL PLC/ADR from an “underweight” rating to a “neutral” rating in a research note on Monday, June 3rd.

About Axcella Health

There is no company description available for Axcella Health Inc

Read More: Forex

Receive News & Ratings for Axcella Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Axcella Health and related companies with MarketBeat.com’s FREE daily email newsletter.